This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Oryzon Genomics S.a.. Active years: 2019-2026.
Company Filing History:
Years Active: 2019-2026
Title: Fiona Mack - Innovator in Cancer Treatment
Introduction
Fiona Mack is a prominent inventor based in New York, NY (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of therapeutic combinations.
Latest Patents
Fiona holds 1 patent for her invention titled "Combinations of LSD1 inhibitors for use in the treatment of solid tumors." This invention relates to therapeutic combinations of LSD1 inhibitors and one or more other active pharmaceutical ingredients or pharmaceutically acceptable salts. The combinations are particularly useful for treating neoplastic diseases, such as cancer, with a focus on small cell lung cancer (SCLC).
Career Highlights
Fiona Mack has established herself as a key figure in the pharmaceutical industry. Her work at Oryzon Genomics S.A. has been instrumental in advancing cancer therapies. She is dedicated to improving treatment options for patients suffering from various forms of cancer.
Collaborations
Fiona collaborates with notable colleagues, including Mark D Demario and Tamara Maes. Their combined expertise enhances the research and development efforts at Oryzon Genomics S.A.
Conclusion
Fiona Mack's innovative work in cancer treatment exemplifies the impact of dedicated inventors in the medical field. Her contributions continue to pave the way for advancements in therapeutic options for patients.